Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Abbott Labs wins FDA approval for AIDS drug

Published on .

Abbott Laboratories received Food & Drug Administration approval for retonivir--a promising new class of AIDS drug that is a protease inhibitor--branded as Norvir. Hoffmann-La Roche's protease inhibitor, Invirase, was the first, approved in December and FDA's acceptance of Merck & Co.'s Crixivan is imminent. The Abbott and Merck brands are likely to get direct-to-consumer ads.

Most Popular
In this article: